BioSpace News Archive

Biotech Bay

Ossium Health Awarded $3.46M in Funding from the California Institute of Regenerative Medicine (CIRM) to Advance the Development of OSSM-007 for the Treatment of Steroid-Refractory Acute Graft versus Host Disease (GVHD)

Ossium Health, Inc. announced that the California Institute of Regenerative Medicine has awarded the company a $3.46M Clinical Stage Research Program grant to support the continued clinical development of OSSM-007, Ossium’s interferon-gamma primed mesenchymal stem cell product, for the treatment of steroid-refractory acute graft versus host disease.

April 28, 2023
·
1 min read
Business

Quarterly Activities and Cashflow Report

Bionomics Limited, a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders with high unmet medical need, released its Appendix 4C – Quarterly Cashflow Report.

April 28, 2023
·
5 min read
Genetown

ConcertAI’s TeraRecon Adds the Releases of an AI-Assisted Clinical Suite Solution, Neuro Suite to Provide Comprehensive Solutions for Neurological Disorders

ConcertAI’s TeraRecon has announced the release of its AI-driven clinical suite, Neuro Suite.

April 28, 2023
·
3 min read